Telix Pharmaceuticals Limited (TLX)
NASDAQ: TLX · Real-Time Price · USD
9.68
+0.39 (4.20%)
Sep 10, 2025, 4:00 PM - Market closed
Telix Pharmaceuticals Market Cap
Telix Pharmaceuticals has a market cap or net worth of $3.21 billion as of September 10, 2025. Its market cap has decreased by -23.46% in one year.
Market Cap
3.21B
Enterprise Value
3.43B
1-Year Change
-23.46%
Ranking
Category
Stock Price
9.68
Market Cap Chart
Since November 15, 2017, Telix Pharmaceuticals's market cap has increased from $115.28M to $3.21B, an increase of 2,688.38%. That is a compound annual growth rate of 53.01%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 10, 2025 | 3.21B | -36.95% |
| Dec 31, 2024 | 5.10B | 129.18% |
| Dec 29, 2023 | 2.22B | 42.30% |
| Dec 30, 2022 | 1.56B | -2.70% |
| Dec 31, 2021 | 1.61B | 96.45% |
| Dec 31, 2020 | 817.72M | 196.48% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Nov 15, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 673.34B |
| Johnson & Johnson | 421.94B |
| AbbVie | 370.57B |
| UnitedHealth Group | 310.09B |
| AstraZeneca | 251.31B |
| Novartis AG | 248.23B |
| Novo Nordisk | 236.38B |
| Abbott Laboratories | 225.86B |